CLINICAL ADVANTAGES OF DMEK
The transplantation of the extremely thin lamella promises a significantly quicker visual recovery than the DSAEK. The DMEK avoids the interface issue, induces no postoperative astigmatism or myopia and substitutes more endothelial cells (up to 9.5 mm transplant size). Therefore in many cases, a visual improvement of 0.8 or more is achieved within a week. Due to the very good results, the DMEK could become the standard
procedure for the therapy of endothelial diseases.
Daybreak Medical Product Range
We offer a comprehensive range of products suitable for all aspects of Ophthalmology across multiple World leading brands.